ReviewJournal of clinical medicine2026
The Evolution of Proximal Femur Hemiepiphysiodesis in Children with Cerebral Palsy.
Review in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hip displacement is a common and progressive musculoskeletal complication in children with cerebral palsy (CP), often driven by coxa valga, muscle imbalance, and spasticity. While proximal femoral and pelvic osteotomies remain the standard treatment for advanced deformity, proximal femoral guided growth (temporary medial hemiepiphysiodesis) has emerged as a minimally invasive alternative for selected patients with remaining growth potential. This narrative review summarizes the current evidence regarding indications, surgical technique, radiographic outcomes, complications, and future directions for proximal femoral guided growth in CP. The literature, consisting primarily of retrospective case series and one systematic review, consistently demonstrates improvements in migration percentage, head-shaft angle, and acetabular index, particularly when treatment is performed early in children with migration percentages below 50% and combined with soft tissue release. Younger age and less severe hip displacement are associated with more favorable outcomes. The most common complication is screw migration as the physis grows off the implant, frequently necessitating revision, although serious complications are uncommon. Concerns remain regarding premature physeal closure and potential femoral head deformity at skeletal maturity. Current evidence supports proximal femoral guided growth as a valuable intermediate treatment that may delay or reduce the need for reconstructive osteotomy in appropriately selected patients; however, high-quality prospective studies are needed to define better its long-term safety, efficacy, and optimal role in treatment algorithms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.